ArticleJournal of clinical microbiology2021
New Names for Fungi of Medical Importance: Can We Have Our Cake and Eat It Too?
Article in Journal of clinical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Antifungal treatment strategies and their impact on resistance development in clinical settings.The Journal of antimicrobial chemotherapy · 2025Review
- Name changes for fungi of medical importance, 2022-2024.Journal of clinical microbiology · 2025Review
- Name changes for fungi of medical importance, 2022-2024.Journal of clinical microbiology · 2025Review
- Nomenclature for human and animal fungal pathogens and diseases: a proposal for standardized terminology.Journal of clinical microbiology · 2024Review
- Article
- Changes in fungal taxonomy: mycological rationale and clinical implications.Clinical microbiology reviews · 2023Review
- A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC.Journal of clinical microbiology · 2023Article
- Insights and advances in recurrent vulvovaginal candidiasis.PLoS pathogens · 2023Article
- Reply to "Re: Fungal Nomenclature: Managing Change Is the Name of the Game".Open forum infectious diseases · 2023Article
- Name Changes for Fungi of Medical Importance, 2020 to 2021.Journal of clinical microbiology · 2023Review
- Fungal Nomenclature: Managing Change is the Name of the Game.Open forum infectious diseases · 2023Review
- Differential Response ofAntimicrobial agents and chemotherapy · 2022Article
- Nomenclatural issues concerning cultured yeasts and other fungi: why it is important to avoid unneeded name changes.IMA fungus · 2021Article
- Reply to Kidd et al., "New Names for Fungi of Medical Importance: Can We Have Our Cake and Eat It Too?"Journal of clinical microbiology · 2021Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.